This company listing is no longer active
23Q Stock Overview
VIVO Cannabis Inc. produces and sells cannabis products for the medical and adult-use markets in Canada, Germany, and Australia.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
VIVO Cannabis Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.014 |
| 52 Week High | CA$0.05 |
| 52 Week Low | CA$0.009 |
| Beta | 2.12 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -70.29% |
| 3 Year Change | -90.53% |
| 5 Year Change | -98.43% |
| Change since IPO | -97.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| 23Q | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 32.7% | 2.1% | 1.6% |
| 1Y | -70.3% | -26.3% | 6.4% |
Return vs Industry: 23Q underperformed the German Pharmaceuticals industry which returned -10.2% over the past year.
Return vs Market: 23Q underperformed the German Market which returned -9.5% over the past year.
Price Volatility
| 23Q volatility | |
|---|---|
| 23Q Average Weekly Movement | 41.4% |
| Pharmaceuticals Industry Average Movement | 6.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 23Q's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 23Q's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 155 | Ray Laflamme | https://vivocannabis.com |
VIVO Cannabis Inc. produces and sells cannabis products for the medical and adult-use markets in Canada, Germany, and Australia. It offers dried cannabis flower products, pre-rolls, and cannabis oils; and cannabis-derived products under the Canna Farms, Beacon Medical, Fireside, and Lumina brands, as well as provides cannabis-related medical information and services. The company also operates a network of medical cannabis clinics under the Harvest Medicine brand; and HMED Connect telemedicine platform, an online medical cannabis store.
VIVO Cannabis Inc. Fundamentals Summary
| 23Q fundamental statistics | |
|---|---|
| Market cap | €6.32m |
| Earnings (TTM) | -€32.98m |
| Revenue (TTM) | €17.31m |
0.4x
P/S Ratio-0.2x
P/E RatioIs 23Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 23Q income statement (TTM) | |
|---|---|
| Revenue | CA$25.41m |
| Cost of Revenue | CA$17.30m |
| Gross Profit | CA$8.11m |
| Other Expenses | CA$56.53m |
| Earnings | -CA$48.41m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.13 |
| Gross Margin | 31.93% |
| Net Profit Margin | -190.52% |
| Debt/Equity Ratio | 8.1% |
How did 23Q perform over the long term?
See historical performance and comparison